The p value measured every week showed a decreasing trend (from 0.50 at 13 weeks to 0.20 at 25 weeks), suggesting that sustained canagliflozin treatment could potentially mitigate body weight gain.
← all excerpts
Canagliflozin-induced renal glutathione distribution mapping in non-diabetic male rat kidneys.
1
—
—